Contribution of GPR30 for 1,25 dihydroxyvitamin D 3 protection in EAE

Metabolic Brain Disease

Volumn 27, Issue 1, 2012, Pages 29-35

  Subramanian, Sandhya ^a   Miller, Lisa M ^a,b   Grafe, Marjorie R ^b   Vandenbark, Arthur A ^a,b,c   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Affairs Medical Center   (United States)

Author keywords

1,25 dihydroxyvitamin D 3; EAE; Estrogen; GPR30

Indexed keywords

CALCITRIOL; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; G PROTEIN COUPLED RECEPTOR 30; INTERLEUKIN 10; INTERLEUKIN 6; RANTES; CCR1 PROTEIN, MOUSE; CCR3 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; GPR30 PROTEIN, MOUSE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 50), ALA(37); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-50), ALA(37)-; PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; MOUSE; NONHUMAN; SPLEEN CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROTECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; SPLEEN;

MUS;

ANIMALS; CALCITRIOL; CHEMOKINE CCL5; CYTOPROTECTION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECEPTORS, CCR1; RECEPTORS, CCR3; RECEPTORS, CHEMOKINE; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SPLEEN;

EID: 84861821689     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-011-9266-6     Document Type: Article

References (22)

1. Byrne IM, Flanagan L, Tenniswood MP, Welsh J (2000) Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 141:2829-2836 (Pubitemid 32250445)
2. Carlyle IP (1997) Multiple sclerosis: a geographical hypothesis. Med Hypotheses 49(6):477-486 (Pubitemid 28009182)
3. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogeninduced activation of Erk-1 and Erk-2 requires the G proteincoupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14(10):1649-1660
4. Goverman JM (2011) Immune tolerance in multiple sclerosis. Immunol Rev 241(1):228-240
5. Harari M, Dramsdahl E, Shany S, Baumfeld Y, Ingber A, Novack V, Sukenik S (2011) Increased vitamin D serum levels correlate with clinical improvement of rheumatic diseases after Dead Sea climatotherapy. Isr Med Assoc J 13(4):212-215
6. Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 82(3):317-322
7. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE (2011) 1, 25-dihydrocyvitamin D3 acts direclty on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelits. European Journal of Immunology 41:822-832
8. Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P (2011) Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest 40(6):627-639
9. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832-2838 (Pubitemid 44969183)
10. Nashold FE, Spach KM, Spanier JA, Hayes CE (2009) Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol 183(6):3672-3681
11. Ramagopalan SV, Handel AE, Giovannoni G, Rutherford Siegel S, Ebers GC, Chaplin G (2011) Relationship of UVexposure to prevalence of multiple sclerosis in England. Neurology 76(16):1410-1414
12. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307(5715):1625-1630 (Pubitemid 40354745)
13. Sadovnick AD (2009) European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. J Neurol Sci 286(1-2):1-5
14. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, Fonseca SG, Van Grevenynghe J, Boulassel MR, Bruneau J, Shoukry NH, Routy J-P, Douek DC, Haddad EK, Sekaly R-P (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16(4):452-459
15. Smolders J (2011) Vitamin D and multiple sclerosis: correlation, causality, and controversy. Autoimmune Dis doi:10.4061/2011/629538
16. Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119-4126 (Pubitemid 41292076)
17. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K (2010) Oral administration of an active form of vitamin D3(calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30 (12):2495-2503
18. Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, Costenbader KH, Karlson EW (2010) Association between residences in U. S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study. Environ Health Perspect 118(7):957-961
19. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, The Pregnancy In Multiple Sclerosis Group (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127(Pt 6):1353-1360 (Pubitemid 38745513)
20. Wang C, Dehghani B, Li Y, Kaler L, Proctor T, Vandenbark AA, Offner H (2009) Membrane estrogen receptor agonist regulates EAE through upregulation of programmed death-1. Journal of Immunology 182:3294-3303
21. Wang C, Dehghani B, Magrisso IJ, Rick EA, Bonhomme E, Cody DB, Elenich LA, Subramanian S, Murphy SJ, Kelly MJ, Rosenbaum JS, Vandenbark AA, Offner H (2008) GPR30 contributes to estrogeninduced thymic atrophy. Mol Endocrinol 22(3):636-648 (Pubitemid 351397791)
22. Wu GF, Alvarez E (2011) The immunopathophysiology of multiple sclerosis. Neurol Clin 29(2):257-278